We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
989

Sector Composition

Rank Sector Weight
1 Technology 6.08%
2 Financials 6.03%
3 Industrials 5.01%
4 Consumer Discretionary 4.73%
5 Healthcare 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GALT icon
7376
PUT
Galectin Therapeutics
GALT
$196M
$69K ﹤0.01%
+20,600
New +$52.1K
GSAT icon
7377
PUT
Globalstar
GSAT
$10.7B
$69K ﹤0.01%
3,527
-2,860
-45% -$65.1K
MUX icon
7378
CALL
McEwen Inc
MUX
$1.03B
$69K ﹤0.01%
3,010
+1,740
+137% +$35.1K
SANW
7379
CALL
DELISTED
S&W Seed Co
SANW
$69K ﹤0.01%
+937
New +$58.9K
RJA
7380
DELISTED
AB Svensk Ekportkredit ELEMENTS Linked to the Rogers International Commodity Index-Agriculture Total Return
RJA
$69K ﹤0.01%
+11,469
New +$69.2K
MDWD icon
7381
MediWound
MDWD
$181M
$68K ﹤0.01%
+2,194
New +$73.9K
SPWH icon
7382
CALL
Sportsman's Warehouse
SPWH
$44.5M
$68K ﹤0.01%
+10,300
New +$49.4K
VUZI icon
7383
CALL
Vuzix
VUZI
$194M
$68K ﹤0.01%
+10,800
New +$62.5K
NYMX
7384
CALL
DELISTED
Nymox Pharmaceutical Corp
NYMX
$68K ﹤0.01%
20,600
-1,000
-5% -$3.65K
SEAC
7385
DELISTED
Seachange International Inc
SEAC
$68K ﹤0.01%
+865
New +$51.1K
TA
7386
DELISTED
TravelCenters of America LLC
TA
$67K ﹤0.01%
+3,276
New +$76K
TCON
7387
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$66K ﹤0.01%
+99
New +$59.8K
PLUR icon
7388
Pluri
PLUR
$16.7M
$65K ﹤0.01%
590
+244
+71% +$30.5K
TTPH
7389
PUT
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$65K ﹤0.01%
+515
New +$65.9K
LABD icon
7390
CALL
Direxion Daily S&P Biotech Bear 3X ETF
LABD
$70.6M
$64K ﹤0.01%
7
-1
-13% -$9.96K
PTN
7391
Palatin Technologies
PTN
$13.7M
$64K ﹤0.01%
60
+13
+28% +$13.5K
KDMN
7392
DELISTED
Kadmon Holdings, Inc.
KDMN
$64K ﹤0.01%
+17,594
New +$62.8K
FATE icon
7393
Fate Therapeutics
FATE
$286M
$63K ﹤0.01%
+10,370
New +$46.3K
KMDA icon
7394
Kamada
KMDA
$412M
$63K ﹤0.01%
+13,184
New +$62.1K
WTI icon
7395
PUT
W&T Offshore
WTI
$534M
$63K ﹤0.01%
19,000
+6,300
+50% +$19.5K
ISEE
7396
PUT
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$63K ﹤0.01%
20,100
+4,200
+26% +$11.8K
TNAV
7397
DELISTED
Telenav Inc.
TNAV
$63K ﹤0.01%
+11,535
New +$64.4K
ANTH
7398
CALL
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$63K ﹤0.01%
+38,300
New +$65.9K
LLEX
7399
DELISTED
Lilis Energy, Inc. Common Stock
LLEX
$63K ﹤0.01%
+12,311
New +$59.4K
AENZ
7400
DELISTED
Aenza S.A.A.
AENZ
$62K ﹤0.01%
+7,298
New +$82.7K

Similar funds

Citadel Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Citadel Advisors held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Citadel Advisors deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Citadel Advisors's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Citadel Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Citadel Advisors's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Citadel Advisors opened 1,440 new positions and closed 989 in Q4 2017.
  • Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.